Alberto Romero-Mate
Overview
Explore the profile of Alberto Romero-Mate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baeza-Hernandez G, Rubio-Aguilera R, Horcajada-Reales C, Khedaoui R, Romero-Mate A
Australas J Dermatol
. 2024 Jan;
65(3):e66-e68.
PMID: 38212933
No abstract available.
2.
Dauden E, Escario E, Martos-Cabrera L, Armesto S, Herrera-Acosta E, Vidal D, et al.
Int J Dermatol
. 2024 Jan;
63(4):503-511.
PMID: 38168847
Background: Biological therapy dose modification is a common practice in the long-term treatment of plaque psoriasis. Objective: The objective of the study was to determine prevalence, characteristics of patients, effectiveness,...
3.
Baeza-Hernandez G, Vallejo-Ruiz M, Rubio-Aguilera R, Romero-Mate A, Martinez-Moran C
Dermatol Pract Concept
. 2023 Mar;
13(1).
PMID: 36892381
No abstract available.
4.
Chicharro P, Llamas-Velasco M, Armesto S, Herrera Acosta E, Vidal D, Vilarrasa E, et al.
Dermatol Ther
. 2022 Oct;
35(12):e15929.
PMID: 36223184
The aim of the study was to assess the long-term effectiveness and safety of secukinumab in Spanish patients with moderate-to-severe psoriasis in a daily practice setting. Nationwide multicenter, observational, retrospective,...
5.
Herrero-Ruiz S, Garrido-Rios A, Romero-Mate A, Khedaoui R, Fernandez de la Fuente L, Borbujo J
Int J Dermatol
. 2022 Oct;
62(2):197-198.
PMID: 36200587
No abstract available.
6.
Martos-Cabrera L, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, et al.
Int J Dermatol
. 2022 Jul;
62(3):e146-e149.
PMID: 35867958
No abstract available.
7.
Chicharro P, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, et al.
Dermatol Ther
. 2022 Jun;
35(8):e15653.
PMID: 35731640
Psoriasis is a chronic dermatological disease with great impact on patients' quality of life (QoL). The main objective of this study was to assess the impact of secukinumab treatment on...
8.
Reolid A, Armesto S, Sahuquillo-Torralba A, Torres T, Feltes R, Vilarrasa E, et al.
J Am Acad Dermatol
. 2022 May;
87(3):705-709.
PMID: 35640798
No abstract available.
9.
Dauden E, de Lima G, Armesto S, Herrera-Acosta E, Vidal D, Villarasa E, et al.
Dermatol Ther (Heidelb)
. 2021 Sep;
11(6):2207-2215.
PMID: 34561788
Introduction: There is limited and conflicting evidence over the real-world drug survival of secukinumab (SEC) in patients with psoriasis, especially in the long term. Our objective was to analyze the...
10.
Company-Quiroga J, Alique-Garcia S, Romero-Mate A
Clin Cosmet Investig Dermatol
. 2019 Oct;
12:721-732.
PMID: 31632120
Discoid lupus erythematosus is the most disfiguring and common presentation of chronic cutaneous lupus erythematosus. Although most patients will respond to lifestyle measures and topical treatment, a non-negligible number of...